Impact of meningococcal group B OMV vaccines, beyond their brief
Meningococcal group B outer membrane vesicle vaccines have been used widely in Cuba, New Zealand, and Brazil. They are immunogenic and initially assessed largely by their ability to induce serum bactericidal activity. Measures of efficacy indicate good protection against homologous strains in older...
| Главный автор: | |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
Taylor & Francis Group
2018-05-01
|
| Серии: | Human Vaccines & Immunotherapeutics |
| Предметы: | |
| Online-ссылка: | http://dx.doi.org/10.1080/21645515.2017.1381810 |